Latest Milestone Payments News

Liontown Limited has secured a staged farm-in agreement to acquire up to 100% of the Centenario lithium brine project in Argentina, marking its first foray into brine resources alongside its established Australian hard-rock operations.

Osteopore Limited’s half-year results show an 8% revenue drop driven by currency effects, while losses widen 14% as the company invests heavily in product development and market growth.

Asara Resources has more than doubled its Kada Gold Project resource to 2.1 million ounces, including 1.3 million ounces in the indicated category, following a 73,000-metre drilling campaign. The company is fully funded to complete a Definitive Feasibility Study by mid-2027, positioning itself for rapid development in Guinea’s prolific Siguiri Basin.

West Wits Mining has transitioned from developer to producer with first gold poured at Qala Shallows, backed by a $97 million project finance package and a resource base expanded to 7.24 million ounces.

CurveBeam AI’s FY2026 results show a 28% revenue decline and a 12% increase in net loss, while advancing its China commercialisation and robotic surgery integration strategies. The company also announced a $6-7 million capital raise post-year-end.

BluGlass Limited reported a 5% reduction in its net loss to A$10.39 million for FY26 despite a 10% revenue dip, boosted by new US defence and industry contracts and a significant capital raise to fund growth.

Syntara Limited’s FY2026 results show a 7.9% revenue decline and a 13.6% increase in net loss amid significant clinical progress, including FDA backing for its lead drug amsulostat and a successful $8.8 million capital raise.

Acrux Limited reported a 46% revenue increase to $6.6 million in FY26, driven by US generic product royalties and licensing milestones, while narrowing its net loss by 90%. The company is pivoting towards developing a female testosterone therapy with encouraging Phase II data and active regulatory engagement.

Neuren Pharmaceuticals reported an 8% rise in H1 2026 revenues driven by DAYBUE royalties, but profit fell 68% due to ramped-up R&D. The company declared its first ever dividend, signalling confidence amid ongoing clinical and regulatory milestones.

Bayan Mining has finalised the sale of its Bayan Springs North Project to Sun Silver, securing upfront and contingent payments while retaining a 1% royalty to maintain exposure to future exploration success.

Sinclair Gold has cleared a key drilling milestone at its Mt Henry project, prompting a $5 million cash payment to Westgold and cancelling over 7.5 million performance rights. The company also moves closer to completing a royalty deal with Stria Lithium, while preparing for a resource update by year-end.

Neuren Pharmaceuticals’ partner Acadia Pharmaceuticals secured European Commission approval for DAYBU (trofinetide) to treat Rett syndrome symptoms in patients aged five and older, marking the first EU-authorised treatment for this condition.